BioCentury
ARTICLE | Clinical News

Clolar clofarabine: Completed Phase II enrollment

December 10, 2007 8:00 AM UTC

GENZ completed enrollment of 109 treatment-naïve AML patients who are unlikely to benefit from standard induction therapy in the pivotal, U.S. Phase II CLASSIC II trial of IV clofarabine. The agent al...